The Role of CD98 in Astrocytic Neoplasms
- 1 February 2002
- journal article
- review article
- Published by Springer Nature in Human Cell
- Vol. 15 (1) , 25-31
- https://doi.org/10.1111/j.1749-0774.2002.tb00096.x
Abstract
The high expression of CD98 was reported in some normal tissues, including blood brain barrier, activated lymphocytes, the basal layer of skin, proximal tubles of kidney, placenta, testis and a wide variety of tumors. The CD98 complex consists of an 80–85kD heavy chain (4F2hc/FRP-1) and a 40–45kD light chain. CD98hc, 4F2hc, and FRP-1 are the same glycosylated protein each other and define antigenicity of CD98. LAT1, the sodium-independent L-type amino acid transporter 1, has been identified as a light chain of the CD98 heterodimer from C6 glioma cells. LAT1 also corresponds to TA1, an oncofetal antigen that is expressed primarily in fetal tissues and cancer cells such as glioma cells. Increased LAT1 expression was found in various malignancies including human gliomas. Several studies implicated the important role of LAT1 and 4F2hc in malignant transformation and carcinogenesis. The LAT1-CD98 pathway may represent a unique therapeutic target for cancer intervention.Keywords
This publication has 38 references indexed in Scilit:
- 3-[123I]iodo-α-methyl-l-tyrosine transport and 4F2 antigen expression in human glioma cellsNuclear Medicine and Biology, 2001
- TA1/LAT-1/CD98 Light Chain and System L Activity, but Not 4F2/CD98 Heavy Chain, Respond to Arginine Availability in Rat Hepatic CellsJournal of Biological Chemistry, 2000
- Class- and Splice Variant-specific Association of CD98 with Integrin β Cytoplasmic DomainsJournal of Biological Chemistry, 2000
- Malignant Transformation of NIH3T3 Cells by Overexpression of Early Lymphocyte Activation Antigen CD98Biochemical and Biophysical Research Communications, 1999
- Suppression of FRP-1/CD98-Mediated Multinucleated Giant Cell and Osteoclast Formation by an Anti-FRP-1/CD98 mAb, HBJ 127, That Inhibits c-src ExpressionCellular Immunology, 1999
- Induction of Human Osteoclast-like Cells by Treatment of Blood Monocytes with Anti-Fusion Regulatory Protein-1/CD98 Monoclonal AntibodiesJournal of Bone and Mineral Research, 1998
- Regulation of human immunodeficiency virus gp160-mediated cell fusion by antibodies against fusion regulatory protein 1Journal of General Virology, 1996
- The Amino Acid Transport System y+L Induced in Xenopus laevis Oocytes by Human Choriocarcinoma Cell (JAR) mRNA Is Functionally Related to the Heavy Chain of the 4F2 Cell Surface AntigenBiochemistry, 1995
- The Human 4F2 Antigen: Evidence for Cryptic and Noncryptic Epitopes and for a Role of 4F2 in Human T Lymphocyte ActivationCellular Immunology, 1994
- Identification of a 140‐kDa activation antigen as a target structure for a series of human cloned natural killer cell linesEuropean Journal of Immunology, 1984